Isolagen to Present at the 2007 CIBC World Markets 18th Annual Healthcare Conference
October 30 2007 - 9:00AM
PR Newswire (US)
EXTON, Pa., Oct. 30 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc.
(AMEX:ILE) today announced that Nicholas L. Teti, Jr., Isolagen
Chairman and Chief Executive Officer, will present at the 2007 CIBC
World Markets 18th Annual Healthcare Conference on November 6, 2007
at 8:35 a.m. EST. The conference will be held at the
Waldorf-Astoria in New York City. The presentation will be webcast
live and can be accessed by visiting the investor relations section
of the Company's website at http://www.isolagen.com/. An archive of
the presentation will be available on the Company's website for 30
days following the conference. About Isolagen, Inc. Isolagen(TM),
Inc. (AMEX:ILE) is an aesthetic and therapeutic company committed
to developing and commercializing scientific advances and
innovative technologies. The company's technology platform includes
the Isolagen Process(TM), a cell processing system for skin and
tissue rejuvenation which is currently in clinical development for
a broad range of aesthetic and therapeutic applications including
wrinkles, acne scars, burns and periodontal disease. Isolagen also
commercializes a scientifically-advanced line of skincare systems
through its majority-owned subsidiary, Agera(R) Laboratories, Inc.
For additional information, please visit http://www.isolagen.com/.
Isolagen Forward Looking Statements All statements in this news
release that are not based on historical fact are "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 and the provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. While management has
based any forward-looking statements contained herein on its
current expectations, the information on which such expectations
were based may change. These forward-looking statements rely on a
number of assumptions concerning future events and are subject to a
number of risks, uncertainties, and other factors, many of which
are outside of our control, that could cause actual results to
materially differ from such statements. Such risks, uncertainties,
and other factors include, but are not necessarily limited to,
those set forth under Item 1A "Risk Factors" in the Company's
Annual Report on Form 10-K for the year ended December 31, 2006, as
updated in "Item 1A. Risk Factors" in the Company's Quarterly
Reports on Form 10-Q. We operate in a highly competitive and
rapidly changing environment, thus new or unforeseen risks may
arise. Accordingly, investors should not place any reliance on
forward-looking statements as a prediction of actual results. We
disclaim any intention to, and undertake no obligation to, update
or revise any forward-looking statements. Readers are also urged to
carefully review and consider the other various disclosures in the
Company's Annual Report on Form 10-K for the year ended December
31, 2006, as well as other public filings with the SEC since such
date. DATASOURCE: Isolagen, Inc. CONTACT: Media, Mike Beyer, Sam
Brown Inc., +1-773-463-4211, ; Investors, Charles Huiner, Isolagen,
+1-484-713-6200, Web site: http://www.isolagen.com/
Copyright
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jul 2023 to Jul 2024